Merck

Congo to begin Ebola vaccinations on Monday
Yahoo/Reuters
Sun, 05/20/18 - 11:11 am
Congo
ebola virus
vaccines
Merck
JNJ
5 takeaways from the first look at cancer's biggest conference
Biopharma Dive
Thu, 05/17/18 - 10:44 pm
ASCO
Regeneron
cemiplimab
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
Nektar
NKTR-214
Loxo Oncology
LOXO-292
Jounce Therapeutics
JTX-2011
Merck's Keytruda boosts response in hard-to-treat lung cancer
Reuters
Thu, 05/17/18 - 10:06 am
Merck
Keytruda
squamous cell lung cancer
Merck's experimental Ebola shot gets set to fight deadly new outbreak in Congo
Fierce Pharma
Mon, 05/14/18 - 11:01 pm
Merck
ebola virus
Moderna’s Billions: Will Building Big Before an IPO Pay Off?
Xconomy
Wed, 05/9/18 - 09:29 pm
Merck
Moderna Therapeutics
IPOs
Neon Therapeutics Treats First Patient in Ph Ib Trial Evaluating Personal Cancer Vaccine NEO-PV-01 Plus Keytruda/Chemo Combination
CP Wire
Tue, 05/8/18 - 11:34 am
Neon Therapeutics
NEO-PV-01
Merck
Keytruda
personalized medicine
OncoSec to combine ImmunoPulse device with Merck’s immunotherapy in breast cancer trial
Drug Delivery Business News
Tue, 05/8/18 - 11:28 am
OncoSec Medical
Merck
ImmunoPulse IL-12
Keytruda
triple negative breast cancer
Merck Teams With Moderna To Take On One Of The Toughest Targets In Cancer
Forbes
Thu, 05/3/18 - 11:17 pm
Keytruda
Merck
Moderna
cancer vaccines
Merck study may signal doom for a broad group of pivotal Alzheimer’s studies
Endpoints
Thu, 05/3/18 - 11:43 am
BACE
Alzheimer's disease
Merck
verubecestat
Exelixis and Invenra Partner to Develop Novel Biologics for Cancer Treatment
CP Wire
Thu, 05/3/18 - 11:09 am
Exelixis
Invenra
cancer
Merck
drug development
A tale of two lung cancer immunotherapies: Merck's Keytruda takes the reins
Medical Marketing and Media
Wed, 05/2/18 - 12:01 pm
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Merck posts strong first-quarter profit, but revenue light
Yahoo/AP
Tue, 05/1/18 - 09:29 pm
Merck
earnings
Merck has submitted Keytruda combination for FDA approval
Marketwatch
Mon, 04/30/18 - 09:29 am
Merck
Keytruda
FDA
U.S. court upholds dismissal of $200 million Merck verdict against Gilead
Reuters
Thu, 04/26/18 - 07:31 pm
Merck
Gilead Sciences
patents
hepatitis C
Merck’s Relebactam Met Primary Endpoints in Phase 3 Study
Market Realist
Mon, 04/23/18 - 09:18 am
Merck
relebactam
beta-lactamase inhibitors
clinical trials
Merck pits its pneumococcal shot against Pfizer's mammoth Prevnar in head-to-head ph3
Fierce Pharma
Wed, 04/18/18 - 09:50 am
Merck
pneumococcal disease
V114
Pfizer
Prevnar 13
Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more
CNBC
Mon, 04/16/18 - 09:46 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
non-small cell lung cancer
AACR
AstraZeneca and Merck Present Updated Overall Survival Data for Lynparza in gBRCA-mutated HER2-Negative Metastatic Breast Cancer
CP Wire
Mon, 04/16/18 - 09:04 am
AstraZeneca
Merck
Lynparza
metastatic breast cancer
AACR
AstraZeneca and Merck Present Updated Overall Survival Data for Lynparza in gBRCA-mutated HER2-Negative Metastatic Breast Cancer
Mon, 04/16/18 - 01:21 am
AstraZeneca
Merck
Lynparza
HER-2 negative breast cancer
breast cancer
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
Sun, 04/15/18 - 10:04 pm
lung cancer
cancer
Merck
Roche
Bristol-Myers Squibb
AACR
non-small cell lung cancer

Pages